Sign in

Annie Joseph

@anniejoseph.bsky.social
2.5K followers 678 following 276 posts

Clinical Microbiologist. Women's infection health, urology, antimicrobial stewardship, diagnostics. Associate Editor @ CMI Communications.

PostsRepliesMedia
Reposted by Annie Joseph
ESGUTI Study Group (ESCMID) @esguti-studygroup.bsky.social · 17/09/2026
Asymptomatic bacteriuria in pregnancy: should we test, treat, or rethink? 🤰 Join us for our next webinar featuring expert speakers Jane Currie making the case for screening and Brenda Kazemier making the case against. Register here: us06web.zoom.us/meeting/regi...
042
Annie Joseph @anniejoseph.bsky.social · 17/09/2026
So excited for this episode, as we head into the northern hemisphere flu season... the first few cases now coming into our hospital... what do we do... 🤔 🤷 #IDsky #clinmicro
193
Reposted by Annie Joseph
Daniel Padfield @padpadpadpad.bsky.social · 15/09/2026
I have an MRC-funded PhD project available (gw4biomed.ac.uk/how-does-tem...) on how warming will change the problem of AMR. Join a small and friendly group (padpadpadpad.netlify.app/about) in (sometimes) sunny Cornwall. 🧪🦠 #microsky **Please share** the ad below with anyone who may be interested.
32930
Reposted by Annie Joseph
Prof Jenny Rohn @jennyrohn.bsky.social · 15/09/2026
Our latest paper has been featured in Nature Comms' Editors’ Highlights page for Microbiology and Infection Diseases! Do check out the paper if you're interested in #UTI, #phage, #UPEC, advanced infection #models & treatment failure! #UTISky #MicroSky #IDSky www.nature.com/articles/s41...
Screenshot of this webpage - who knows how long our paper will last on it ;-) 

https://www.nature.com/collections/jedgcgeija
1219
Reposted by Annie Joseph
Rossana Rosa @drrossanarosa.bsky.social · 09/09/2026
It’s coming back!!!!!!!! 💫💫💫 #IDSky
0174
Reposted by Annie Joseph
Angela Huttner @angelahuttner.bsky.social · 07/09/2026
This one just makes me smile Henning recites Danish poetry 🫶 We learn POET 1 started with a case series, n=12 (every piece of evidence matters!) The two guests are so humble, thoughtful and curious Have a bit of host-envy, @gurujosh.bsky.social & @dremilymcd.bsky.social!! #IDSky #MedSky
194
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 06/09/2026
🎙️ Just published Communicable E62: the 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditis Hosted by Emily McDonald & Josh Davis with invited guests Henning Bundgaard and Sami El-Dalati 🌟 Listen on #Communicable: share.transistor.fm/s/d5eb49ac #IDSky
1122
Annie Joseph @anniejoseph.bsky.social · 28/08/2026
Last chance to register! Webinar later today... #IDsky #UTIsky
032
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 23/08/2026
🎙️ Just published Communicable E61: We will make you love PK/PD, part 3 Hosted by Amy Legg, Rekha Pai & Angela Huttner with invited guests Amanda Gwee (@amandagwee.bsky.social) & Sebastian Wicha 🌟 Listen on #Communicable: share.transistor.fm/s/c4af55ab #IDSky #clinmicro
share.transistor.fm
Communicable | Communicable E61: We will make you love PK/PD, part 3
064
Reposted by Annie Joseph
ESGUTI Study Group (ESCMID) @esguti-studygroup.bsky.social · 19/08/2026
Our next AMAZING webinar is just around the corner- sign up now!! 😍🤩🥳 #IDSky #UTISky #ESCMID #ESGUTI us06web.zoom.us/meeting/regi...
032
Reposted by Annie Joseph
Angela Huttner @angelahuttner.bsky.social · 24/07/2026
So proud of our @cmicomms.bsky.social editorial fellow Victor Dahl for his gorgeous essay in @thelancetinfdis.bsky.social The Optimism in Front of Us. #IDSky #clinmicro @hoferu.bsky.social www.thelancet.com/journals/lan...
thelancet.com
The optimism in front of us
The world often feels dark when seen through today's headlines. Conflict, division, mistrust, and crisis compete for attention.1 However, working and training in infectious diseases offers a different...
0106
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 24/07/2026
📣 New evidence that #UTI & bacterial vaginosis exist on a continuum of dysbiosis. In this metagenomic study of >600 adults, women with UTI symptoms were nearly 3x more likely to have Nugent #BV. #Lactobacillus crispatus is a protector. #IDSky #UTISky #MicroSky www.cmi-comms.org/article/S295...
cmi-comms.org
Vaginal dysbiosis is associated with urinary symptoms and urinary tract infection: A case–control study
Limited data suggest that bacterial vaginosis (BV) and the composition of the vaginal microbiome may be associated with urinary symptoms and urinary tract infection (UTI). We investigated these relati...
194
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 09/07/2026
📣New #Communicable drops Mon 13 July! Angela Huttner & Josh Davis are joined by Prof Brett Mitchell, Aline Wolfensberger & Lauren Clack to discuss the HAPPEN trial, a multicentre RCT showing impressive reductions in hospital-acquired #pneumonia, and the studies that led to it.🎙️ #IDSky #clinmicro
085
Reposted by Annie Joseph
UTI Global Alliance @globaluti.bsky.social · 06/07/2026
Mark your calendars, our next #UTIHour is TWO WEEKS FROM TODAY! What: A 60-minute seminar on Understudied Uropathogens! When: 7/20, 1:30PM EDT/1730 UTC Where: UTIGA.org/upcoming Who: follow this account to find out 👀👀 #UTISky #IDsky
023
Reposted by Annie Joseph
id-journal.bsky.social @id-journal.bsky.social · 28/06/2026
Endourology post-op UTI rate: 4.2% (8⃣/190), with 53% pre-op urine culture +, 26.7% multi-resistant⬆. Longer wait (291 vs 115 days)🔗infection risk. No ICU admissions.🛡️
academic.oup.com
P45 Analysing the impact of a novel microbiology MDT on endourology surgical outcomes in a complex tertiary centre
Post-operative urinary infection following endourology surgery occurs in approximately 7%–10% of cases and is more common in prolonged or complex procedures.1,2,3 Infective complications may lead to significant morbidity, including prolonged hospitalization, readmission, or critical care admission. As a regional tertiary urology centre managing complex endourological referrals, the patient cohort at Nottingham Urology Centre is inherently high risk.ObjectivesTo mitigate this, we implemented a pioneering and novel microbiology-led multidisciplinary team (MDT) model, incorporating mandatory pre-operative urine culture and individualized antimicrobial prophylaxis. We aimed to evaluate post-operative infection outcomes following endourological interventions in our tertiary centre.MethodsA retrospective cohort study was conducted including 190 elective endourological patients in a 3-month period (Jan-Apr 2025). All patients underwent procedures with ureteric involvement; diagnostic or therapeutic rigid or flexible ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), or ureteric stent exchange. We analysed surgical indication, waiting time for operation, ASA grading, whether patients had received interim procedures such as nephrostomy or emergency stent placement, urine microbiology results (including presence of multi-resistant pathogens), and postoperative infection rates (including critical care admission, prolonged hospital stay or readmission for infection). Cohort A comprised patients that experienced either prolonged hospital stays, or readmission within 14 days, for infection reasons. Cohort B included patients with no prolonged hospital stays or readmission within 14 days for infective symptoms.ResultsOf 190 patients, the median age was 63, with an average wait time of 118.5 days. There were 31 Stent changes, 27 PCNLs, 5 TURBTs with URS and 127 URS. The median wait time for PCNL was 199 days and for URS 136 days. 74 patients had interim operations (either stent or nephrostomy) and 85 were primary cases. 69 patients (38%) required run in antibiotics prior to the operation with 121 requiring only prophylaxis on the day of operation. All patients had a pre-operative urine culture performed. 53% of patients had microbiologically significant growth of a uropathogen, of which 26.7% had multi-resistant organisms. 6.8% of patients were treated for UTI symptoms within 30 days of procedure. 4.2% of patients had a post-operative infection with either prolonged post-operative hospital stay, or readmission within 30 days with infection symptoms (Cohort A). The median length of prolonged stays and readmissions was 3.5 days. There were zero post-operative admissions to critical care in the 190 patients over 3 months. Only 50% of Cohort A had post-operative urine or blood cultures that were positive. 75% of Cohort A had significant growth on pre-operative urine culture compared to 52% of Cohort B. 62.5% of Cohort A required run in antibiotics compared to 35% in Cohort B, Cohort A were more likely to require run-in antibiotics (P=0.08). Cohort A had a significantly longer waiting time compared to Cohort B (P=0.049) (median 291 versus 115 days) and were likely to have a higher ASA grade (P=0.07).ConclusionsOur MDT approach to endourology surgery with mandatory urine culture and tailored antibiotic prophylaxis is associated with low post-operative infection rates, despite high clinical complexity and urine culture positivity. Despite over half of patients demonstrating significant pre-operative microbial growth and a substantial proportion harbouring multi-resistant organisms, infective complications prolonging hospital stay or causing readmission occurred in only 4.2% of cases, with no critical care admissions. Pre-operative urine culture positivity and longer waiting times were associated with the development of post-operative infective complications. These findings suggest that minimizing waiting times, particularly in complex cases, may further reduce post-operative infection risk. Our microbiology-integrated MDT model represents an effective model to deliver good infection outcomes in complex endourological patients.
011
Reposted by Annie Joseph
Clinical Microbiology and Infection @cmijournal.bsky.social · 18/05/2026
📣 In the June 2026 issue: Monotherapy vs. combination therapy for Enterococcus faecalis bacteraemia: a target trial emulation www.clinicalmicrobiologyandinfection.org/article/S119...
032
Annie Joseph @anniejoseph.bsky.social · 16/06/2026
Interested in UTI prevention? Join the @esguti-studygroup.bsky.social webinar 'Expert Perspectives on Methenamine Hippurate' on Wednesday 24th June 13.00 Central Europe time. #UTIsky #IDsky Sign-up: gbr01.safelinks.protection.outlook.com?url=https%3A...
gbr01.safelinks.protection.outlook.com
ESGUTI webinar registration
ESGUTI will be hosting a webinar over Zoom on Wednesday 24th June 13:00 Central Europe time: "Expert perspectives on methenamine hippurate for UTI prevention". Please register using the form below, t...
196
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 14/06/2026
🎙️ Just published Communicable E56: Frequentist vs Bayesian for clinical trial analysis – 99% probability you’ll want to listen to this Hosted by Emily McDonald & Josh Davis with invited guests Roger Lewis & Ian Marschner 🌟 Listen on #Communicable: share.transistor.fm/s/7ea020d2 #IDSky
0125
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 12/06/2026
📣 If you have questions about fosfomycin, we have answers! Excellent review article by Tiffany Wu, Kalpana Gupta, @erinmccreary.bsky.social, Sarah Turbett & Jacob Lazarus on oral #fosfomycin & how to use it. #IDSky #clinmicro #UTISky #Medsky #Pharmsky www.cmi-comms.org/article/S295...
cmi-comms.org
Oral fosfomycin tromethamine for UTI: Guidance for clinicians
Oral fosfomycin is a guideline-recommended first-line treatment for uncomplicated cystitis. However, fosfomycin has demonstrated lower clinical and/or microbiological cure rates compared with other an...
085
Reposted by Annie Joseph
Anita Williams @catanita.bsky.social · 12/06/2026
A great episode to learn more about the current Ebola outbreak, if nothing else but to learn how to pronounce Bundibugyo #IDSky #IDEpi
043
Reposted by Annie Joseph
ESGUTI Study Group (ESCMID) @esguti-studygroup.bsky.social · 05/06/2026
☀️ Don’t forget to sign for our next WEBINAR “Expert perspectives on Methenamine Hippurate for UTI prevention” ☀️ 🔜 24th June 13:00 CET ✍️ escmid.wufoo.com/forms/r1ijmo... 🥳 We are so excited to welcome you to another great ESGUTI webinar! Don’t miss out! #ESGUTI #IDSky #UTISky
156
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 31/05/2026
🎙️ Just published Communicable E54: ESCMID Global Late Breakers, part 2 Hosted by our editors - Erin McCreary, PharmD, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner 🌟 Listen on #Communicable: share.transistor.fm/s/a8cc04bb #ESCMIDGlobal2026 #IDSky #clinmicro
075
Reposted by Annie Joseph
ESGUTI Study Group (ESCMID) @esguti-studygroup.bsky.social · 21/05/2026
Sign up now for our next ESGUTI webinar on June 24th! It’s gonna be AMAZING!!! 🥳🤩 #ESGUTI #IDSky #UTISky #ESCMID
155
Reposted by Annie Joseph
Angela Huttner @angelahuttner.bsky.social · 17/05/2026
Doing some final editing on next #Communicable ep & found spot where @marcbonten.bsky.social tells us how the FAST RCT got a waiver of informed consent. Anne-Grete and I start dreaming here: our countries would not let us do this. Vanderbilt is a learning health system w/ ethics oversight.🤩 #IDSky
Anne-Grete Märtson, Erin McCreary, Josh Davis, Angela Huttner, and Marc Bonten on a screen having an online conversation about trials.
172
Reposted by Annie Joseph
David van Duin @davidvanduin.bsky.social · 14/05/2026
Dr. Donnelly of JAC fame describes common perception of reviewers in medical publishing. @bsacandjac.bsky.social #IDsky
074
Reposted by Annie Joseph
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 09/05/2026
🆕💥🔴Target trial emulation using a multicenter cohort of critically ill adults with influenza from 48 ICUs Early antifungal prophylaxis did not reduce influenza-associated pulmonary aspergillosis (IAPA) incidence overall #idsky www.clinicalmicrobiologyandinfection.org/article/S119...
clinicalmicrobiologyandinfection.org
Early antifungal prophylaxis fails to prevent influenza-associated pulmonary aspergillosis in the ICU: a target trial emulation
To evaluate whether early antifungal prophylaxis reduces the incidence of influenza-associated pulmonary aspergillosis (IAPA) in critically ill adults with influenza.
183
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 08/05/2026
Our collaboration episode with Breakpoints covering the trials from the ESCMID Global session 'The trial run' is out now! share.transistor.fm/s/e2a9aee4 🎙️✨ @erinmccreary.bsky.social @gurujosh.bsky.social @jesusrbano.bsky.social #IDSky #clinmicro
share.transistor.fm
Communicable E52: ESCMID Global Trials, PETER PEN and ASTARTE | Communicable | Episode 52
In this collaborative episode of Breakpoints and Communicable, the hosts revisit the “trial run” session from ESCMID Global, a format designed to facilitate critical discussion of major infectious dis...
1129
Reposted by Annie Joseph
Prof Jenny Rohn @jennyrohn.bsky.social · 05/05/2026
😱 Take-home message: hospital sinks are perfectly safe if you don’t run the taps! #IDSky
096
Annie Joseph @anniejoseph.bsky.social · 28/04/2026
The British Society for Antimicrobial Chemotherapy has reached a milestone of 10,000 members! Although British in name, our membership is global 🌎 and so is our mission - to improve antimicrobial use 💊 and patient care 💖 @bsacandjac.bsky.social
020
Reposted by Annie Joseph
Rossana Rosa @drrossanarosa.bsky.social · 27/04/2026
At #ESCMID2026 Trial Run session, Dr. David. Paterson made a call to the ID community to join platform trials. So I want to tell you how we did that. I am a clinician, and also medical lead for IPC and stewardship. Our small but mighty ASP was already reviewing all pts with bacteremia 1/ #IDSky
2135
Reposted by Annie Joseph
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 20/04/2026
🔥 💥Late-Breakers |COBRA RCT 1-day of antibiotic treatment after adequate endoscopic biliary drainage is non-inferior to 4-7 days in adults with acute cholangitis. 💡 Shorter is better+source control Practice-changing? #ESCMIDGlobal2026 #idsky
02910
Annie Joseph @anniejoseph.bsky.social · 20/04/2026
Preach!! @nicoledenisco.bsky.social is always such an impactful speaker & the room was truly hers for this talk! So good to see the urobiome in the mainstream on the big stage at infection conferences 💜 #UTIsky #clinmicro #ESCMIDGlobal2026
170
Reposted by Annie Joseph
Gabriele Pollara @gpollara.bsky.social · 19/04/2026
Normal urine is not sterile! Urine microbiome being introduced by @nicoledenisco.bsky.social #ESCMIDGlobal2026 #UTISky
25516
Annie Joseph @anniejoseph.bsky.social · 15/04/2026
Total flight chaos, so I will be taking a rather...roundabout...route to get to Munich, but my excitement for #ESCMIDGlobal2026 is still high! Hope to see/meet #IDSky & #clinmicro Bluesky folk there! 🤓 🔬 🍻 @escmid.bsky.social
3110
Annie Joseph @anniejoseph.bsky.social · 08/04/2026
🎙 Ep 50 🎙 Communicable is here! And it's the inaugural "Quarterly Catch-up" on the literature with @cmicomms.bsky.social editors Emily, Nav & Thomas. There's something for everyone in this ep...TB, gut microbiota, Wolbachia, Staph, Steno, HIV... Enjoy!! 🤓 📚 🤓 #IDsky #ClinMicro
081
Reposted by Annie Joseph
Rossana Rosa @drrossanarosa.bsky.social · 02/04/2026
My outfit today was a conversation starter 💁🏻‍♀️ Hope folks will remember the message 😅 #IDSky #IPSky
Me wearing a sweatshirt with the message “clean the shared equipment “
3206
Reposted by Annie Joseph
ESGUTI Study Group (ESCMID) @esguti-studygroup.bsky.social · 25/03/2026
Dear ESGUTIs, we would LOVE your support on two ongoing surveys within ESGUTI! Please vote and spread the word, we need your expertise 🤩🫶 Thank you, you are the BEST! #UTISky #ESGUTI #ESCMID #IDSky
033
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 19/03/2026
📣 New #Communicable drops Monday, 23 March! Angela Huttner & Marc Bonten host Martin Grobusch & Pikka Jokelainen of the ESCMID Emerging Infections Subcommittee to discuss how to deal with outbreaks, what One Health really means, and the launch of the esteemed Epi Alert. 🎙️ #IDSky #clinmicro
031
Annie Joseph @anniejoseph.bsky.social · 09/03/2026
Sex & gender in Infection... its complicated!!! Such a pleasure to host these guests alongside @erinmccreary.bsky.social #IDSky #UTIsky #clinmicro @escmid.bsky.social
093
Annie Joseph @anniejoseph.bsky.social · 06/03/2026
Celebrating World Book Day tonight with the wonderful clever women in our book club, 'Reading Between The Wines'. My 2025 New Years' resolution of starting a book club is turning out so much better than I could have anticipated 🍷 📚 🤓 💖
030
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 26/02/2026
📣 Person behind the name Riichi Sakazaki identified Enterobacter sakazakii, a cause of neonatal sepsis The genus was renamed Cronobacter after Cronos, the Greek god who devoured his children to prevent their supplanting him #IDSky #clinmicro Saied Ali ow.ly/ifFo50YlJkp
ow.ly
Of titans and taxonomy: The naming of Cronobacter sakazakii
042
Reposted by Annie Joseph
ESGUTI Study Group (ESCMID) @esguti-studygroup.bsky.social · 17/02/2026
Register now for our first webinar of 2026!!! 🎉🥳🎊 #UTISky #IDSky #ESGUTI #ESCMID
053
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 12/02/2026
📣 What is a #WISCA? It's something you should probably use for culture-negative prosthetic joint infections. Local antibiograms alone can be misleading. This WISCA showed that doxycycline + a fluoroquinolone offer best coverage for #PJI #IDSky #clinmicro #ortho www.cmi-comms.org/article/S295...
cmi-comms.org
Weighted-incidence syndromic combination antibiogram (WISCA) to guide antibiotic regimens for empiric treatment of prosthetic joint infections: A retrospective cohort study
Prosthetic joint infections (PJIs) are now routinely treated with oral antibiotics, but selecting empiric regimens is challenging, including for treatment of culture-negative PJIs. Although antibiogra...
0127
Reposted by Annie Joseph
Journal of Hospital Infection @thejhi.bsky.social · 10/02/2026
📘Infection Prevention in Practice (IPIP) is seeking a new Editor to join the team📘 If you are passionate about IPC and wish to contribute to the international academic community, we encourage you to apply. ▶️Read more and apply now: ow.ly/GRlJ50Y08mL
002
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 22/01/2026
📣 New #Communicable drops Mon 26 Jan! In our last episode, we brought you some favorite #clinmicro papers of 2025. We continue this thread in our next episode with top ID papers of 2025, picked by our editors, Josh Davis & Emily McDonald and guest, Steven Tong. ⭐ Tune in Monday🎙️ #IDSky
085
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 20/01/2026
📣 A peer reviewer used #AI to create a fake review with 6 self-citation prompts. But is s/he the only perpetrator in our system? In the year's first editorial, Angela Huttner explores the depths of the academic-industrial complex. #IDSky #clinmicro #peerreview ow.ly/juoW50Y05t6
ow.ly
The beating heart of a broken machine
21410
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 12/01/2026
📣 Who is behind #Kingella kingae, #Elizabethkingia meningoseptica, and several other bacteria? Anne-Marie Dolan et al describe the legacy of Elizabeth O. King, #CDC microbiologist & World War II army officer, for our #Personbehindthename series. #IDSky #clinmicro www.cmi-comms.org/article/S295...
cmi-comms.org
Microbiology royalty: Elizabeth O. King and the legacy of Elizabethkingia meningoseptica
The genus Elizabethkingia comprises Gram-negative, nonmotile, nonspore-forming aerobic rods in the family Weeksellaceae. These nonglucose-fermenting organisms were long included within Flavobacterium ...
110330
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 11/01/2026
🎙️ Just published Communicable E44: Top clinical microbiology papers in 2025 Hosted by Annie Joseph & Josh Nosanchuk w/ invited guests Robin Patel & Fidelma Fitzpatrick Listen on #Communicable: share.transistor.fm/s/6e5c26ae #IDSky #clinmicro
0105
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 08/01/2026
📣 New #Communicable drops Mon 12 Jan! We kick off the new year with Annie Joseph & Josh Nosanchuk hosting Robin Patel (Mayo Clinic) & Fidelma Fitzpatrick (RCSI) to discuss their top #clinmicro papers of 2025 ⭐ Tune in Monday🎙️ #IDSky
0134
Reposted by Annie Joseph
CMI Communications @cmicomms.bsky.social · 06/01/2026
📣 #Wastewater surveillance is a powerful tool. In this integrated molecular epidemiologic study of >1000 patients with #influenza, #RSV, or #Covid, it correlates year after year with number of inpatient + ambulatory cases. #IDSky #clinmicro #ViroSky #EpiSky #OA www.cmi-comms.org/article/S295...
cmi-comms.org
An integrated surveillance study of SARS-CoV-2, influenza virus, and respiratory syncytial virus infections
We aimed to describe recent epidemiological trends of SARS-CoV-2, influenza virus (A/B), and respiratory syncytial virus (RSV) in the canton of Geneva, Switzerland, using data from the Sentinella netw...
0163